Exploring Breakthroughs in Neurological Research

Clinical Trials Advancing Neurology

Welcome to our comprehensive resource for ongoing and completed clinical trials in neurology. Discover the latest advancements and research efforts aimed at improving patient outcomes.

Innovative Treatments

Discover cutting-edge therapies being tested to enhance patient care.

Global Collaboration

Join our worldwide network of researchers and healthcare professionals.

Ongoing Clinical Trials

ALXN-MG-501

Principal Investigator: Dr. Smith

Long-term observational study on C5 inhibition therapies for generalized myasthenia gravis.

Multicenter, global registry.

Focus on patient outcomes and therapy effectiveness.

Open for enrollment.

Efgartigimod PH20 SC Study

Principal Investigator: Dr. Johnson

Phase 2/3 study evaluating efficacy and safety in idiopathic inflammatory myopathy.

Randomized, double-blind, placebo-controlled.

Participants aged 18 and older.

Seamless study design.

Egfartigimod PH20 SC Outcomes

Principal Investigator: Dr. Lee

Phase 4 study on clinical outcomes in new onset generalized myasthenia gravis.

Open-label, prospective study.

Single group, multicenter approach.

Focus on real-world effectiveness.

IMVT-1402 Efficacy Study

Principal Investigator: Dr. Patel

Phase 3 study assessing efficacy in mild to severe generalized myasthenia gravis.

Randomized, placebo-controlled, double-blind.

Multicenter trial.

Focus on safety and tolerability.

HyQvia Real-World Study

Principal Investigator: Dr. Kim

Global study on HyQvia use in CIDP patients.

Focus on outcomes and therapy transition.

Real-world data collection.

Open for participation.

IMVT-1402 CDP Study

Principal Investigator: Dr. Brown

Phase 2b study on IMVT-1402 treatment in CDP.

Randomized, double-blind, placebo-controlled.

Multicenter approach.

Focus on safety and efficacy.

MMN Longitudinal Study

Principal Investigator: Dr. Davis

Study on clinical outcomes and disease course in MMN.

Prospective, multicenter study.

Focus on quality of life and healthcare utilization.

Ongoing data collection.

Additional Ongoing Trials

Explore more ongoing trials on our website.

Join our research community.

Contribute to groundbreaking discoveries.

Stay informed about new developments.

Contact us for more information.

Completed Clinical Trials

IVIG in DIN Study

Principal Investigator: DDF

Evaluated IVIG in dysimmune inflammatory neuropathy with/without diabetes mellitus.

Focused on safety and efficacy outcomes.

ADHERE Trial

Principal Investigator: Dr. White

Phase 2 trial on efgartigimod PH20 SC in CIDP patients.

Investigated efficacy, safety, and tolerability.

ADHERE+ Extension

Principal Investigator: Dr. Green

Open-label extension of ARGX-113-1802 trial in CIDP.

Assessed long-term safety and efficacy.

MG 0017 Study

Principal Investigator: Dr. Black

Open-label study on subcutaneous zilucoplan in generalized myasthenia gravis.

Evaluated safety and efficacy in previous IV C5 inhibitor recipients.

Understanding Our Clinical Trials

Our clinical trials are pivotal in advancing the field of neurology, focusing on innovative treatments for complex neurological disorders. These trials aim to evaluate the safety and efficacy of novel therapies, providing hope and improved outcomes for patients worldwide. By conducting rigorous and comprehensive studies, we contribute to the development of groundbreaking treatments that can transform lives and enhance the quality of care for those affected by neurological conditions.

Meet Our Research Experts

Our Dedicated Research Team

Dr. Emily Carter

Dr. Emily Carter

Principal Investigator

Dr. John Smith

Dr. John Smith

Lead Neurologist

What Our Participants Say

Participating in the trial gave me hope and a new perspective on managing my condition. The team's dedication was truly inspiring.

James Thompson

The professionalism and care provided by the research team made me feel valued and supported throughout the process.

Sarah Johnson

Thanks to the trial, I have seen significant improvements in my symptoms. I am grateful for the opportunity to be part of such important research.

Michael Lee

The insights gained from this trial have been invaluable. The team's expertise and compassion were evident at every step.

Laura Martinez

Being part of this trial was a life-changing experience. The innovative approach and thoroughness of the study were impressive.

David Brown

I felt reassured by the team's commitment to patient care and the potential impact of their research on future treatments.

Emma Wilson

Phone

(123) 456-7890

Address

Clinical Research Center, 5678 Health Ave, Boston, MA 02115

Join Our Clinical Trials

Explore the opportunity to contribute to groundbreaking research in the field of neurology. Join our clinical trials today and help advance medical science. Click the button to learn more about our ongoing studies and how you can participate.